Ex Post-Evaluation Brief India: Polio Immunisation Programme, Phases I to VII

Similar documents
Ex post evaluation India

Ex post evaluation Tanzania

Ex Post-Evaluation Brief Yemen: Family Planning and Family Health

Ex post evaluation Indonesia

Ex Post-Evaluation Brief ETHIOPIA: Family Planning and HIV Prevention I and II

Ex Post-Evaluation Brief BURUNDI: Health Sectoral Programme II

Cote d Ivoire: Family Planning and HIV Prevention

Burkina Faso: PROMACO II and III /STD control including HIV/AIDS BMZ project ID Phase II ) Phase III )

Chad: Family Planning / HIV Prevention I to III 2.) ) ) GFA Medica 3.) GFA Medica 2.) Q

Ex Post-Evaluation Brief CENTRAL AMERICA: HIV/AIDS Prevention

Ex post evaluation Burundi

All About Vaccines and How They Get to Those Who Need Them Most. Elesha Kingshott

How to present the European Vaccine Action Plan (EVAP)

Gavi, the Vaccine Alliance - Health System and Immunisation Strengthening (HSIS) Support Framework

Rwanda: HIV Prevention (Social Marketing) Phases I and II /STD control including HIV/AIDS (Phase I); (Phase II)

Poliomyelitis eradication in the WHO European Region

Bangladesh Resource Mobilization and Sustainability in the HNP Sector

KURUKSHETRA JULY 2017 RURAL HEALTH

Achieving Polio Eradication in India. Emergency Preparedness and Response Plan 2011

Polio and measles control: opportunities and threats for health systems

ANNEX Page. AFR/RC61/11 4 July 2011 ORIGINAL: ENGLISH REGIONAL COMMITTEE FOR AFRICA

Polio and routine immunisation Alan Brooks

Ensuring the quality of polio outbreak response activities: A rationale and guide for 3 month, quarterly and 6 month independent assessments

Rotavirus Vaccine. Supply and Procurement Roadmap. The Market Shaping Goal. Public Summary. Rotavirus Supply and Procurement Roadmap UPDATE 2016

POLIO ERADICATION IN THE AFRICAN REGION: PROGRESS REPORT. Information document EXECUTIVE SUMMARY

Report to the. GAVI Alliance Board June 2013

TERMS OF REFERENCE. Regional Immunization Program. Department of Family, Gender and Life Course

International PolioPlus Committee PolioPlus Facts and Figures June Rotary s financial contribution to the polio eradication effort:

Fact sheet. Poliomyelitis. WHO Media centre. ADAPTED FOR ADDITION TO THE RHIZOME POLIOK.IT PLATFORM 16 Jan 2017 INFORMATION FOR ERADICATION FROM

NHS public health functions agreement Service specification No.9 DTaP/IPV and dtap/ipv pre-school booster immunisation programme

Report. 10 th Meeting of the Expert Review Committee (ERC) on Polio Eradication in Nigeria

History and aims of immunisation. Dr Anna Clarke Department of Public Health Dr. Steevens Hospital Dublin 8

In the Name of God, the Compassionate, the Merciful. Address by DR HUSSEIN A. GEZAIRY REGIONAL DIRECTOR WHO EASTERN MEDITERRANEAN REGION.

Navigating vaccine introduction: a guide for decision-makers JAPANESE ENCEPHALITIS (JE) Module 4. How should my country introduce JE vaccines?

D.A.Henderson, MD, MPH. Professor of Medicine, University of Pittsburgh Honorary Fellow, London School of Hygiene and Tropical Medicine

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HUMANITARIAN AID - ECHO. Emergency Humanitarian Aid Decision

Ex Post-Evaluation Brief NIGER: Social Marketing for HIV Prevention (Phases I and II)

Expanded Programme on Immunization

10 th Annual African Vaccinology Course (AAVC) Cape Town 10 November 2014

UNICEF Procurement Advancements DCVMN Annual Meeting Hanoi, Vietnam October 2013

Manojkumar Choudhary 1, Roma Solomon, Jitendra Awale and Rina Dey

Guide on Access to the Yellow Fever ICG Stockpile. Emergency Campaigns. International Coordinating Group on Vaccine. Geneva, Switzerland 2012

Progress report on eradication of poliomyelitis: regional implications of the endgame strategy

FISCAL YEAR 2020 APPROPRIATIONS REQUESTS (updated ) USAID Global Health Programs (GHP) and State Department

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services

Classification: official 1

Oral Polio Vaccine Supply Outlook. UNICEF Supply Division

FINAL RECOMMENDATIONS ON PANDEMIC INFLUENZA

Summary. Project title: HIV/AIDS and Tuberculosis Control Project Cooperation scheme: Technical Cooperation Total cost:approximately 452 million yen

Polio Eradication Rotary s Commitment & Global Partnership. Carol Wells District 6440 EPN Chair

3/25/2018. End Polio Now an Update. Type 3 has not been seen since The Polio Virus. Polio What is it and Where did it Originate?

Sudan EPI Benefits From Polio Eradication Program

RUSSIA Mobilizing support for the Global Fund to Fight AIDS, Tuberculosis, and Malaria

Report to the Board 6-7 June 2018

External Evaluation of the National Immunisation Programme in Bosnia and Herzegovina

GOAL 2: ACHIEVE RUBELLA AND CRS ELIMINATION. (indicator G2.2) Highlights

Progress in maternal and child health: Uzbekistan and WHO European Region

GAVI, THE VACCINE ALLIANCE

Impact of Immunization on Under 5 Mortality

3. CONCLUSIONS AND RECOMMENDATIONS

Poliomyelitis: successful and critical issues in the eradication process

Tajikistan: Poliomyelitis

OIE/FAO Global Conference on foot and mouth disease. The way towards global control. Paraguay: 24 to 26 June Draft Resolution version 8

NHS public health functions agreement Service specification No.12 Td/IPV (teenage booster) immunisation programme

Botswana Advocacy paper on Resource Mobilisation for HIV and AIDS

Global Health Policy: Vaccines

Report to the. GAVI Alliance Board June Alan Brooks, Special Adviser for Immunisation

GAVI Secretariat response to the IFFIm evaluation

Global reductions in measles mortality and the risk of measles resurgence

Monitoring of the achievement of the health-related Millennium Development Goals

Gavi Alliance Strategy : Goal level indicators and disease dashboard

NHS public health functions agreement

Reducing malaria in Solomon Islands: lessons for effective aid

For Health Worldwide Financing Gavi, the Vaccine Alliance as an investment in the future

Government of Bangladesh

Eradicating Polio: It's Feasibility in Near Future?

LAUNCH OF SOUTH ASIA HUMAN DEVELOPMENT REPORT Rima Salah, Deputy Executive Director, UNICEF UNICEF House 27 July 2005

in control group 7, , , ,

Eradication of poliomyelitis

Targeted Diseases and Immunization. Strategic plan

Preparing for the withdrawal of all oral polio vaccines (OPVs): Replacing trivalent OPV with bivalent OPV

Balance Sheets 1. CHILD HEALTH... PAGE NUTRITION... PAGE WOMEN S HEALTH... PAGE WATER AND ENVIRONMENTAL SANITATION...

PLANNING & EVALUATION WORKBOOK. WEB: FACEBOOK:

topv to bopv FACTSHEET 25 APRIL 2016

Managing constrained vaccine supply: prevention and remediation Lessons learned and ways forward DVCMN Annual Meeting October Bangkok,

Task Force on Immunization (TFI) in Africa 14 th Annual Meeting. And. Africa Regional Inter-Agency Coordination Committee (ARICC) 13 th Annual Meeting

GAVI S CONTINUED ROLE IN YELLOW FEVER CONTROL

Polio & routine immunisation Alan Brooks

Identifying and addressing inequities in child and maternal health provision. Gian Gandhi Health Section, UNICEF NYHQ

EMERGING DISEASES IN INDONESIA: CONTROL AND CHALLENGES

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services

Eradicating Polio: Why and How? Dr Roland Sutter, World Health Organization 20 September 2011

Rotavirus Factsheet What you need to know about Rotavirus

Item 4. Sexual Health and Blood Borne Virus Strategy Strategy for Sexual Health and Blood Borne Viruses. Background

Global Fund Financing of Contraceptives for Reproductive Health Commodity Security

50th DIRECTING COUNCIL 62nd SESSION OF THE REGIONAL COMMITTEE

Assessment of G8 Commitments on Maternal, Newborn and Child Health

m Public health officials Medical administrators Clinicians

Mid-term Review of the UNGASS Declaration of. Commitment on HIV/AIDS. Ireland 2006

Transcription:

Ex Post-Evaluation Brief India: Polio Immunisation Programme, Phases I to VII Polio Immunisation Programme Phases I VII (1996 Programme/Client 66 140; 1999 65 906; 2000 65 581; 2002 66 213; 2002 66 858; 2003 66 724; 2004 65 369) Random sample: Yes (Phases I, IV, V and VI) Programme executing agency Ministry of Health and Family Welfare (MoHFW) of the Republic of India Year of sample/ex post evaluation report: 2010*/2011 Appraisal (planned) Ex post-evaluation (actual) Investment costs (total) EUR 1.09 billion EUR 1.09 billion Counterpart contribution (company) EUR 0.32 billion EUR 0.32 billion Funding, of which budget funds (BMZ) * random sample EUR 77.80 million EUR 77.80 million Project description German FC (Financial Cooperation) has been supporting the Republic of India in polio eradication efforts since 1996. These polio immunisation programmes encompass: the procurement of oral polio vaccine and its distribution to the Indian Federal States; administering the vaccine, both under a routine immunisation programme and in separate mass immunisation drives; supporting public information and awareness-raising campaigns; and the maintenance and expansion of a nationwide polio monitoring system in line with standards set by the World Health Organization (WHO). The FC contribution was primarily used to procure oral polio vaccine and provide refrigeration equipment to safeguard the vaccine cold chain. Phases I VII are comparable in their conceptual design. Ex post evaluation and assessment were therefore conducted jointly across all phases. Objective: The overall developmental objective of the programme was to contribute to the national, and indirectly to the worldwide, eradication of poliomyelitis (the impact). The target date for eradication was adjusted several times in the process. Expectations at the start of the programme were clearly too high. The aim of the programme was to vaccinate all children under the age of five throughout the country during the 1998-2006 immunisation campaigns (the outcome). Despite its weaknesses, the assumed results chain is, by and large, reasonable: the vaccination of every last child (the outcome) will halt the spread of the wild polio virus (the impact). Eradicating polio in India will remove this disease burden, thereby obviating treatment costs and eliminating loss of income (the impact). Target group: All Indian children under the age of five. Overall rating: 3 The ambitious objective of total eradication was missed by a narrow margin. Good efficiency and sustainability were achieved. Of note: Notwithstanding the need for efficient service provision, integrating the vertical programme structure into the health system at an early stage makes good sense, as it ensures that the established structures for planning, monitoring and communication will remain useful once the programme has come to an end. Contrary to current practice at the time of programme appraisal, social factors that have a bearing on immunisation, such as hygiene and nutrition, are nowadays taken into account when making conceptual and strategic programme decisions. Sustainability Efficiency Rating by DAC criteria Performance rating 1 2 3 4 5 6 Overarching development impact Relevance Effectiveness Programme Average rating for sector (starting 2007) Average rating for region (starting 2007)

EVALUATION SUMMARY Overall rating: Given that the overall objectives and programme objectives were missed by only a narrow margin, and that satisfactory relevance and good sustainability have both been achieved in a programme that was logistically challenging to implement, and also taking into consideration the positive net effects achieved in general by this programme, it has been awarded an overall rating of satisfactory. Rating: 3 Relevance: The relevance of the programme must be considered on a number of different levels. At an international level, the relevance of the Polio Immunisation Programme for the Republic of India stems from the overarching international developmental goal of eradicating polio. In terms of global public good, this is to be seen as on a par with the eradication of smallpox. At the ex post evaluation India is still classified as a polio-endemic country; with this in view, it can reasonably be considered that the problem was correctly identified and the programme fully justified. Based on the existing international commitment to the eradication of polio, the programme was and still remains a priority in Indian public health policy. This leads to a positive assessment of its relevance and leads to the programme s congruence with BMZ objectives and guidelines, both at programme appraisal and at the time of the ex post evaluation. Its relevance, however, is to be seen in relation to the health priorities of the target group. Given the prevalence and disease burden of other childhood illnesses (e. g. measles and whooping cough) and in view of the basic health problems that exist in India, the goal of eradicating polio has a somewhat lower priority for the immediate target group. These circumstances weaken the relevance of the programme. The results chain underlying the project is largely reasonable; however, some weaknesses are evident in its overemphasis of technical factors. According to the results chain, the vaccination of every last child (the outcome) will halt the spread of the wild polio virus (the impact). Polio eradication in India will remove this disease burden, obviating treatment costs and eliminating loss of income. This results chain assumes a direct link between vaccination and immunisation, but it neglects the social factors of vaccine efficacy and disease transmission. As a consequence, the programme is too narrow in its design. The programme concept at the time of programme appraisal met the global guidelines of the Global Polio Eradication Initiative, which have proved effective in other geographical regions (e. g. in Latin America and China). However, these no longer reflect current best practice, and this weakens the relevance of Phases I-VII of the project. Since the health system in India has major shortcomings, the programme format that was selected - a vertical structure, designed for the efficient supply of polio vaccine - was deemed generally appropriate for the intended purpose of covering all children under the age of five (Sub- Rating: 3). 2

Effectiveness: The programme objective of Phases I-VII is the intensive, nationwide vaccination of all children in India under the age of five, in order to halt the spread of the wild polio virus. The programme appraisal reports specified the following as programme objective indicators: (a) a vaccination rate of 95% of all children under the age of five (Phase I: 90%); (b) a continuing decline in polio incidence, as defined by the number of cases reported; and consequently (c) a reduction in the number of polio-endemic districts. It should be noted here that indicators (b) and (c) form part of the overall objective. They are used to assess the overarching developmental effects. The indicator (a) of a vaccination rate of 95% of all children under the age of five was specified in order to achieve a minimum rate of 95% in all districts and high-risk areas. Furthermore, the time frame for the achievement of targets for all phases was re-set from the originally specified year 2000 (Phase I) to 2008 (Phase VII). With regard to the vaccination rate achieved in the polio immunisation campaigns, several academic assessments and evaluations carried out within the programme attest to high overall immunisation rates, in the region of the figure of 95% reported. However, these studies also show that during the period 1998-2006, in the remaining high-risk districts and regions often 10% or more of the target group were not vaccinated. (Approximately 25% of the Indian population live in the remaining endemic states of Uttar Pradesh and Bihar.) Overall this has been assessed as Sub-Rating: 3. Efficiency: At USD 0.17 per vaccinated child, India has relatively low operational costs when compared to other countries with cases of polio. Furthermore, in 2010 the cost per case of acute flaccid paralysis in India was the lowest of all countries. Measured against these indicators, the results achieved in relation to the use of resources, in terms of production efficiency, can be assessed as positive. However, it should be noted that existing estimates for the total cost per vaccination (including health sector staff labour costs for the planning and implementation of immunisation campaigns) are somewhat inadequate, so the evaluation of production efficiency contains a certain degree of uncertainty. No data exists to allow for an evaluation of allocative efficiency. From a macroeconomic viewpoint, several sources attribute a high cost-benefit ratio to the eradication of polio, with the results only being seen following the successful eradication of the disease. In contrast to this, the arguments cited under Relevance suggest that the eradication of poliomyelitis is not unquestionably the best possible allocation of resources to improve the basic health of children in India, as it does not deliver wide-ranging effects. Efficiency of implementation can be seen as good overall, especially in relation to the possibility of implementing the programme through the regular channels of the health system. The programmes ran largely according to plan; resources, including refrigeration equipment, were generally supplied on time; the monitoring and reporting system met WHO standards; and experiences with the procurement of vaccine through UNICEF (despite the move to RITES as the buying agent in 2010) were largely positive. 3

Based on the good level of efficiency achieved in production and implementation, and given the limited scope for evaluating allocative efficiency, we award Sub-Rating: 2. Overarching developmental impact: The overall objective of Phases I-VII was to make a contribution to the national and worldwide eradication of polio. At the start of the nationwide vaccination campaign (1994) it was envisaged that this would have been achieved by 2000 (overall objective of Phase I). This expectation was clearly too high. Therefore, in the course of implementation of the immunisation programme, the target date was adjusted (Phase VII, 2008). For the purpose of the ex post evaluation, this last figure is used, presuming a total period of 15 years for the achievement of the objective (1994-2008). The overall objective indicator identified at programme appraisal (all phases) of WHO certification of India as a polio-free country no longer reflects current thinking. The programme objective indicators (b) and (c) above - which identified a reduction in the number of polio cases and polio-endemic districts - can here be seen as modified indicators for the overall objective. The number of registered polio cases does not demonstrate conclusive success. Even though at the time of the ex post evaluation only one case of wild polio virus was reported in 2011, there were also outbreaks of polio following programme Phases I-VII (e.g. 2009: 714 cases). It is therefore still not possible at present to make a statement about whether the disease has really been eradicated in India. This first overall objective indicator (former programme objective indicator b) is therefore deemed not to have been met despite the extended target date. Since polio eradication efforts are now concentrated on the endemic states of Uttar Pradesh and Bihar with their 107 high-risk blocks, it has been possible to establish that the reservoirs of wild polio virus have been restricted to significantly fewer districts. This means the second overall objective indicator (former programme indicator c) has been met. Since Phases I-VII have made a positive contribution to the fight against polio, but the results achieved have not shown any continuous improvement and polio transmission has still not been halted beyond question, we find that the overall objective has been missed by a narrow margin. The Polio Immunisation Programme has had an indirect effect on India s routine vaccination programme in particular. Positive effects have come in the form of a more highly developed cold chain, an increase in demand for health services from patients, and an improvement in the planning processes of the routine immunisation programme. These indirect synergistic effects stand in contrast to the programme s negative and unintended side effects. The prolonged intensity of the Polio immunisation Programme is having a crowding-out effect, interfering with the capacity of the routine immunisation programme to provide vaccinations and thereby meet demand, especially in regions in which more intensive 4

polio immunisation campaigns have been carried out. Given the chronic lack of financial and personal resources in the Indian public health system, the scope of the measures undertaken must therefore be examined critically, even though they are integral to the existing concept of the programme. The positive effects, nevertheless, outweigh any others. Taken overall, we therefore award Sub-Rating: 3. Sustainability: The Ministry of Health has demonstrated that it is determined and able to maintain polio eradication efforts. At present the programme is funded almost exclusively by the project executing agency. Over the course of the programme, its scope has been expanded. In addition, the Polio Immunisation Programme, as indicated above, enjoys priority in Indian health policy. However, at this stage, the extent to which use will be made of the established planning, monitoring, and mobilisation capacities of the Social Mobilisation Network and the National Polio Surveillance Project by the Indian health system, on completion of the programme, can still not be predicted with any reliability. Taken overall we evaluate the sustainability of the project as good (Sub-Rating: 2). 5

Notes on the methods used to evaluate project success (project rating) Projects (and programmes) are evaluated on a six-point scale, the criteria being relevance, effectiveness, efficiency and overarching developmental impact. The ratings are also used to arrive at a final assessment of a project s overall developmental efficacy. The scale is as follows: 1 Very good result that clearly exceeds expectations 2 Good result, fully in line with expectations and without any significant shortcomings 3 Satisfactory result project falls short of expectations but the positive results dominate 4 Unsatisfactory result significantly below expectations, with negative results dominating despite discernible positive results 5 Clearly inadequate result despite some positive partial results, the negative results clearly dominate 6 The project has no impact or the situation has actually deteriorated Ratings 1-3 denote a positive or successful assessment while ratings 4-6 denote a not positive or unsuccessful assessment Sustainability is evaluated according to the following four-point scale: Sustainability level 1 (very good sustainability) The developmental efficacy of the project (positive to date) is very likely to continue undiminished or even increase. Sustainability level 2 (good sustainability): The developmental efficacy of the project (positive to date) is very likely to decline only minimally but remain positive overall. (This is what can normally be expected). Sustainability level 3 (satisfactory sustainability): The developmental efficacy of the project (positive to date) is very likely to decline significantly but remain positive overall. This rating is also assigned if the sustainability of a project is considered inadequate up to the time of the ex post evaluation but is very likely to evolve positively so that the project will ultimately achieve positive developmental efficacy. Sustainability level 4 (inadequate sustainability): The developmental efficacy of the project is inadequate up to the time of the ex post evaluation and is very unlikely to improve. This rating is also assigned if the sustainability that has been positively evaluated to date is very likely to deteriorate severely and no longer meet the level 3 criteria. The overall rating on the six-point scale is compiled from a weighting of all five individual criteria as appropriate to the project in question. Ratings 1-3 of the overall rating denote a "successful" project while ratings 4-6 denote an "unsuccessful" project. It should be noted that a project can generally be considered developmentally successful only if the achievement of the project objective ( effectiveness ), the impact on the overall objective ( overarching developmental impact ) and the sustainability are rated at least satisfactory (rating 3). 6